According to GlobalData’s medical device pipeline database, 57 Smart Health Watches/Wristband devices are in various stages of development globally. GlobalData’s report provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 46 are in active development, while the remaining 13 are in an inactive stage of development. There are 12 products in the early stages of development, and the remaining 34 are in the late stages of development.
Smart Health Watches/Wristband are devices that are worn on the wrist to monitor various vital parameters. They are connected to smartphone app that allows the transfer of data.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
See Also:
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Smart Health Watches/Wristband pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Smart Health Watches/Wristband devices. Overall, most of these Smart Health Watches/Wristband pipeline devices are being developed by private entities.
Key players involved in the active development of Smart Health Watches/Wristband include Ebenroth, PKvitality, Purdue University, Rockley Photonics, Rutgers The State University of New Jersey, Samueli School of Engineering, Sathyabhama Institute of Science and Technology, SugarWare Technologies, Therabracelet and University of California Irvine.
For a complete picture of the developmental pipeline for Smart Health Watches/Wristband devices, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
